Upon examination of several stem-cell-related signaling pathways, we found that PI3K/AKT pathway, a critical pathway involved in pro-survival and pro-stem-cell maintenance [48–52], was preferentially activated in the ex vivo hypoxia-selected breast cancer cells. This evidence concerns the gene AKT1 and breast carcinoma.